These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1269216)

  • 1. Kinetics of the oral antiarrhythmic lidocaine congener, tocainide.
    Lalka D; Meyer MB; Duce BR; Elvin AT
    Clin Pharmacol Ther; 1976 Jun; 19(6):757-66. PubMed ID: 1269216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM; Kates RE
    Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic effects of a lidocaine congener, tocainide, 2-amino-2',6'-propionoxylidide, in man.
    McDevitt DG; Nies AS; Wilkinson GR; Smith RF; Woosley RL; Oates JA
    Clin Pharmacol Ther; 1976 Apr; 19(4):396-402. PubMed ID: 773580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocainide kinetics after intravenous and oral administration in healthy subjects and in patients with acute myocardial infarction.
    Graffner C; Conradson TB; Hofvendahl S; Rydén L
    Clin Pharmacol Ther; 1980 Jan; 27(1):64-71. PubMed ID: 7351118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy of cardiac arrhythmias.
    Heger JJ; Prystowsky EN; Zipes DP
    Cardiol Clin; 1983 May; 1(2):305-22. PubMed ID: 6443562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents.
    Woosley RL; Echt DS; Roden DM
    Am J Cardiol; 1986 Jan; 57(3):25B-33B. PubMed ID: 3080860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Converting patients from intravenous lidocaine to oral tocainide treatment.
    Zhanel GG; Bleske BE
    JAMA; 1986 Jun; 255(24):3361-2. PubMed ID: 3086579
    [No Abstract]   [Full Text] [Related]  

  • 8. Tocainide kinetics and metabolism: effects of phenobarbital and substrates of glucuronyl transferase.
    Elvin AT; Lalka D; Stoeckel K; du Souich P; Axelson JE; Golden LH; McLean AJ
    Clin Pharmacol Ther; 1980 Nov; 28(5):652-8. PubMed ID: 6777107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The appropriate dosage regime for the transition from intravenous lignocaine to oral tocainide after acute myocardial infarction.
    Upward JW; Holt D; Emery P; Akhras F; Jackson G
    Eur J Clin Pharmacol; 1983; 25(5):589-94. PubMed ID: 6420162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocainide. A review of its pharmacological properties and therapeutic efficacy.
    Holmes B; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Aug; 26(2):93-123. PubMed ID: 6411445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent pharmacokinetics of tocainide in the rat.
    Venkataramanan R; Axelson JE
    J Pharmacol Exp Ther; 1980 Oct; 215(1):231-4. PubMed ID: 6778990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy and pharmacokinetics of a new orally effective antiarrhythmic, tocainide.
    Winkle RA; Meffin PJ; Fitzgerald JW; Harrison DC
    Circulation; 1976 Dec; 54(6):885-9. PubMed ID: 791536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of tocainide in patients with combined hepatic and renal dysfunction.
    Oltmanns D; Pottage A; Endell W
    Eur J Clin Pharmacol; 1983; 25(6):787-90. PubMed ID: 6420165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocainide conjugation in humans: novel biotransformation pathway for a primary amine.
    Elvin AT; Keenaghan JB; Byrnes EW; Tenthorey PA; McMaster PD; Takman BH; Lalka D; Manion CV; Baer DT; Wolshin EM; Meyer MB; Ronfeld RA
    J Pharm Sci; 1980 Jan; 69(1):47-9. PubMed ID: 7354440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocainide and mexiletine. Orally effective lidocaine analogues.
    Roden DM
    Arch Intern Med; 1985 Mar; 145(3):417-8. PubMed ID: 3919665
    [No Abstract]   [Full Text] [Related]  

  • 16. Tocainide kinetics in congestive heart failure.
    Mohiuddin SM; Esterbrooks D; Hilleman DE; Aronow WS; Patterson AJ; Sketch MH; Mooss AN; Hee TT; Reich JW
    Clin Pharmacol Ther; 1983 Nov; 34(5):596-603. PubMed ID: 6414753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of phenobarbital and SKF 525A on tocainide pharmacokinetics in the rat.
    Venkataramanan R; Axelson JE
    J Pharmacol Exp Ther; 1980 Oct; 215(1):235-9. PubMed ID: 6778991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and efficacy of pirmenol hydrochloride in the treatment of ventricular dysrhythmia.
    Lee TG; Goldberg AD; Chang T; Serkland MT; Yakatan GJ; Johnson EL; Toole JG; Goldstein S
    J Cardiovasc Pharmacol; 1983; 5(4):632-7. PubMed ID: 6193362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of tocainide in patients with severe renal failure.
    Braun J; Sörgel F; Engelmaier F; Gluth WP; Gessler U
    Eur J Clin Pharmacol; 1985; 28(6):665-70. PubMed ID: 3933983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of tocainide in patients with renal dysfunction and during haemodialysis.
    Wiegers U; Hanrath P; Kuck KH; Pottage A; Graffner C; Augustin J; Runge M
    Eur J Clin Pharmacol; 1983; 24(4):503-7. PubMed ID: 6407848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.